Pharma Journalist - Page 20 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Akari Partners with WuXi XDC on Novel Cancer Therapy

Lilly to Acquire Centessa in $6.3 Billion Deal

Teva Advances Biosimilars With FDA Approval and Filings

Symeres, Ambagon Partner on Novel Cancer Drug Approach

Biogen to Acquire Apellis in $5.6 Billion Deal

FDA Approves Higher-Dose Spinraza Regimen for SMA Patients

In Vivo Cell Engineering Reaches an Inflection Point as the 5th In Vivo Cell Engineering & Gene Editing Summit Returns to Boston

Otsuka to Acquire Transcend in $1.2 Billion Deal

FDA Approves Lifyorli for Platinum-Resistant Ovarian Cancer

Tempus, Daiichi Sankyo Partner to Advance AI-Driven ADC Development